piperidines and Erythema-Multiforme

piperidines has been researched along with Erythema-Multiforme* in 5 studies

Other Studies

5 other study(ies) available for piperidines and Erythema-Multiforme

Article	Year
Switching PARP inhibitors as an effective approach for niraparib-induced erythema multiforme. International journal of dermatology, 2022, Volume: 61, Issue:10 Topics: Erythema Multiforme; Humans; Indazoles; Piperidines; Poly(ADP-ribose) Polymerase Inhibitors	2022
Erythema multiforme-like rash upon anti-melanoma therapy with BRAF and MEK inhibitors. European journal of dermatology : EJD, 2019, Feb-01, Volume: 29, Issue:1 Topics: Azetidines; Erythema Multiforme; Female; Humans; MAP Kinase Kinase 1; Melanoma; Middle Aged; Mutation; Piperidines; Protein Kinase Inhibitors; Proto-Oncogene Proteins B-raf; Skin Neoplasms; Vemurafenib	2019
Image Gallery: Tofacitinib for treatment of herpes-associated erythema multiforme. The British journal of dermatology, 2019, Volume: 181, Issue:5 Topics: Administration, Oral; Drug Administration Schedule; Erythema Multiforme; Female; Herpes Simplex; Herpesvirus 1, Human; Humans; Middle Aged; Piperidines; Pyrimidines; Treatment Outcome	2019
Photo-induced erythema multiforme associated with vandetanib administration. Journal of the American Academy of Dermatology, 2014, Volume: 71, Issue:4 Topics: Aged; Biopsy, Needle; Carcinoma, Medullary; Erythema Multiforme; Follow-Up Studies; Humans; Immunohistochemistry; Male; Neoplasm Staging; Photosensitivity Disorders; Piperidines; Quinazolines; Risk Assessment; Thyroid Neoplasms; Thyroidectomy	2014
Erythema multiforme caused by the H2-blocker, roxatidine. The Journal of dermatology, 2000, Volume: 27, Issue:5 Topics: Adult; Arm; Diagnosis, Differential; Drug Eruptions; Erythema Multiforme; Female; Histamine H2 Antagonists; Humans; Neck; Piperidines	2000